You are on page 1of 30

PULLPILL CASE

GROUP 1
AURELIÉN BOSSET
ANDREJ NASTEVSKI
MANFREDI SOPRANI
ALBERTO ZAGARELLA
JACOPO ZANARDI
1DETERMINISTIC MODEL
(EUR m) 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030

Sales forecast

Market Assumptions
Patients Treated 100,000.0 101,000.0 102,010.0 103,030.1 104,060.4 105,101.0 106,152.0 107,213.5 108,285.7 109,368.5
Patients Expected Market Share 20.00% 21.00% 22.00% 23.00% 24.00% 25.00% 25.00% 25.00% 25.00% 25.00%
Patients 20,000.0 21,210.0 22,442.2 23,696.9 24,974.5 26,275.3 26,538.0 26,803.4 27,071.4 27,342.1
Days of Treatment per year 365 365 365 365 365 365 365 365 365 365
Daily Dosage 2 2 2 2 2 2 2 2 2 2
Pills per pack 60 60 60 60 60 60 60 60 60 60
Total Number of Packs per Patient 12 12 12 12 12 12 12 12 12 12
Total Number of Packs per Patient /
243,333 258,055 273,047 288,313 303,856 319,682 322,879 326,108 329,369 332,663
year
Price per pack (€) 30 31 31 32 32 33 34 34 35 36
Inflation rate 2% 2% 2% 2% 2% 2% 2% 2% 2% 2%
Weighted Average Commercial
7% 7% 7% 7% 7% 7% 7% 7% 7% 7%
Discount

1DETERMINISTIC MODEL
(EUR m) 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030

Sales forecast

Market Assumptions
Patients Treated 100,000.0 101,000.0 102,010.0 103,030.1 104,060.4 105,101.0 106,152.0 107,213.5 108,285.7 109,368.5 Patients treated: 100,000,
Patients Expected Market Share 20.00% 21.00% 22.00% 23.00% 24.00% 25.00% 25.00% 25.00% 25.00% 25.00% supposed to increase 1%
Patients 20,000.0 21,210.0 22,442.2 23,696.9 24,974.5 26,275.3 26,538.0 26,803.4 27,071.4 27,342.1
per year
Days of Treatment per year 365 365 365 365 365 365 365 365 365 365
Daily Dosage 2 2 2 2 2 2 2 2 2 2
Pills per pack 60 60 60 60 60 60 60 60 60 60
Total Number of Packs per Patient 12 12 12 12 12 12 12 12 12 12
Total Number of Packs per Patient /
243,333 258,055 273,047 288,313 303,856 319,682 322,879 326,108 329,369 332,663
year
Price per pack (€) 30 31 31 32 32 33 34 34 35 36
Inflation rate 2% 2% 2% 2% 2% 2% 2% 2% 2% 2%
Weighted Average Commercial
7% 7% 7% 7% 7% 7% 7% 7% 7% 7%
Discount

1DETERMINISTIC MODEL
(EUR m) 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030

Sales forecast

Market Assumptions
Patients Treated 100,000.0 101,000.0 102,010.0 103,030.1 104,060.4 105,101.0 106,152.0 107,213.5 108,285.7 109,368.5
Patients Expected Market Share 20.00% 21.00% 22.00% 23.00% 24.00% 25.00% 25.00% 25.00% 25.00% 25.00% Patients expected Market
Patients 20,000.0 21,210.0 22,442.2 23,696.9 24,974.5 26,275.3 26,538.0 26,803.4 27,071.4 27,342.1 share: 20%, expected to
Days of Treatment per year 365 365 365 365 365 365 365 365 365 365
increase 1% per year in the
Daily Dosage 2 2 2 2 2 2 2 2 2 2
Pills per pack 60 60 60 60 60 60 60 60 60 60
first 5 years, then stable
Total Number of Packs per Patient 12 12 12 12 12 12 12 12 12 12
Total Number of Packs per Patient /
243,333 258,055 273,047 288,313 303,856 319,682 322,879 326,108 329,369 332,663
year
Price per pack (€) 30 31 31 32 32 33 34 34 35 36
Inflation rate 2% 2% 2% 2% 2% 2% 2% 2% 2% 2%
Weighted Average Commercial
7% 7% 7% 7% 7% 7% 7% 7% 7% 7%
Discount

1DETERMINISTIC MODEL
(EUR m) 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030

Sales forecast

Market Assumptions
Patients Treated 100,000.0 101,000.0 102,010.0 103,030.1 104,060.4 105,101.0 106,152.0 107,213.5 108,285.7 109,368.5
Patients Expected Market Share 20.00% 21.00% 22.00% 23.00% 24.00% 25.00% 25.00% 25.00% 25.00% 25.00%
Patients 20,000.0 21,210.0 22,442.2 23,696.9 24,974.5 26,275.3 26,538.0 26,803.4 27,071.4 27,342.1
Days of Treatment per year 365 365 365 365 365 365 365 365 365 365 Days of treatment per year
Daily Dosage 2 2 2 2 2 2 2 2 2 2 = 365; Daily dosage: 2 pills;
Pills per pack 60 60 60 60 60 60 60 60 60 60
Pills x pack = 60
Total Number of Packs per Patient 12 12 12 12 12 12 12 12 12 12
Total Number of Packs per Patient /
243,333 258,055 273,047 288,313 303,856 319,682 322,879 326,108 329,369 332,663
year
Price per pack (€) 30 31 31 32 32 33 34 34 35 36
Inflation rate 2% 2% 2% 2% 2% 2% 2% 2% 2% 2%
Weighted Average Commercial
7% 7% 7% 7% 7% 7% 7% 7% 7% 7%
Discount

1DETERMINISTIC MODEL
(EUR m) 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030

Sales forecast

Market Assumptions
Patients Treated 100,000.0 101,000.0 102,010.0 103,030.1 104,060.4 105,101.0 106,152.0 107,213.5 108,285.7 109,368.5
Patients Expected Market Share 20.00% 21.00% 22.00% 23.00% 24.00% 25.00% 25.00% 25.00% 25.00% 25.00%
Patients 20,000.0 21,210.0 22,442.2 23,696.9 24,974.5 26,275.3 26,538.0 26,803.4 27,071.4 27,342.1
Days of Treatment per year 365 365 365 365 365 365 365 365 365 365
Daily Dosage 2 2 2 2 2 2 2 2 2 2
Pills per pack 60 60 60 60 60 60 60 60 60 60
Total Number of Packs per Patient 12 12 12 12 12 12 12 12 12 12
Total Number of Packs per Patient /
243,333 258,055 273,047 288,313 303,856 319,682 322,879 326,108 329,369 332,663
year
Price per pack (€) 30 31 31 32 32 33 34 34 35 36 Ex Factory Price x pack =
Inflation rate 2% 2% 2% 2% 2% 2% 2% 2% 2% 2% 30€, increasing with an
Weighted Average Commercial
7% 7% 7% 7% 7% 7% 7% 7% 7% 7% inflation rate of 2%
Discount

1DETERMINISTIC MODEL
(EUR m) 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030

Sales forecast

Market Assumptions
Patients Treated 100,000.0 101,000.0 102,010.0 103,030.1 104,060.4 105,101.0 106,152.0 107,213.5 108,285.7 109,368.5
Patients Expected Market Share 20.00% 21.00% 22.00% 23.00% 24.00% 25.00% 25.00% 25.00% 25.00% 25.00%
Patients 20,000.0 21,210.0 22,442.2 23,696.9 24,974.5 26,275.3 26,538.0 26,803.4 27,071.4 27,342.1
Days of Treatment per year 365 365 365 365 365 365 365 365 365 365
Daily Dosage 2 2 2 2 2 2 2 2 2 2
Pills per pack 60 60 60 60 60 60 60 60 60 60
Total Number of Packs per Patient 12 12 12 12 12 12 12 12 12 12
Total Number of Packs per Patient /
243,333 258,055 273,047 288,313 303,856 319,682 322,879 326,108 329,369 332,663
year
Price per pack (€) 30 31 31 32 32 33 34 34 35 36
Inflation rate 2% 2% 2% 2% 2% 2% 2% 2% 2% 2%
Weighted Average Commercial Weighted average commercial
7% 7% 7% 7% 7% 7% 7% 7% 7% 7%
Discount
discount = 7%

1DETERMINISTIC MODEL
(EUR m) 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030

Sales forecast

Costs Assumptions
Raw Materials 6.39 6.39 6.39 6.39 6.39 6.39 6.39 6.39 6.39 6.39
Fixed Costs 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50
COGS x pack adjusted 9.07 9.25 9.44 9.63 9.82 10.01 10.21 10.42 10.63 10.84
Royalties (% of Gross Sales) 20% 20% 20% 20% 20% 20% 20% 20% 20% 20%
Royalties per year (1,460,000.0) (1,579,296.6) (1,704,467.1) (1,835,757.6) (1,973,423.4) (2,117,730.0) (2,181,685.5) (2,247,572.4) (2,315,449.1) (2,385,375.6)
Promotional Expenses per year 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0
Investment Costs (3,500,000.0) (1,000,000.0)
D&A 350,000.0 350,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0

1DETERMINISTIC MODEL
(EUR m) 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030

Sales forecast

Costs Assumptions
Raw Materials 6.39 6.39 6.39 6.39 6.39 6.39 6.39 6.39 6.39 6.39 COGS x pack (including
Fixed Costs 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50
delivery costs) = 9 €,
COGS x pack adjusted 9.07 9.25 9.44 9.63 9.82 10.01 10.21 10.42 10.63 10.84
Royalties (% of Gross Sales) 20% 20% 20% 20% 20% 20% 20% 20% 20% 20%
increasing with an inflation
Royalties per year (1,460,000.0) (1,579,296.6) (1,704,467.1) (1,835,757.6) (1,973,423.4) (2,117,730.0) (2,181,685.5) (2,247,572.4) (2,315,449.1) (2,385,375.6) rate of 2%
Promotional Expenses per year 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0
Investment Costs (3,500,000.0) (1,000,000.0)
D&A 350,000.0 350,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0

1DETERMINISTIC MODEL
(EUR m) 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030

Sales forecast

Costs Assumptions
Raw Materials 6.39 6.39 6.39 6.39 6.39 6.39 6.39 6.39 6.39 6.39
Fixed Costs 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50
COGS x pack adjusted 9.07 9.25 9.44 9.63 9.82 10.01 10.21 10.42 10.63 10.84
Royalties (% of Gross Sales) 20% 20% 20% 20% 20% 20% 20% 20% 20% 20% Royalties = 20% of Gross Sales
Royalties per year (1,460,000.0) (1,579,296.6) (1,704,467.1) (1,835,757.6) (1,973,423.4) (2,117,730.0) (2,181,685.5) (2,247,572.4) (2,315,449.1) (2,385,375.6)
Promotional Expenses per year 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0
Investment Costs (3,500,000.0) (1,000,000.0)
D&A 350,000.0 350,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0

1DETERMINISTIC MODEL
(EUR m) 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030

Sales forecast

Costs Assumptions
Raw Materials 6.39 6.39 6.39 6.39 6.39 6.39 6.39 6.39 6.39 6.39
Fixed Costs 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50
COGS x pack adjusted 9.07 9.25 9.44 9.63 9.82 10.01 10.21 10.42 10.63 10.84
Royalties (% of Gross Sales) 20% 20% 20% 20% 20% 20% 20% 20% 20% 20%
Royalties per year (1,460,000.0) (1,579,296.6) (1,704,467.1) (1,835,757.6) (1,973,423.4) (2,117,730.0) (2,181,685.5) (2,247,572.4) (2,315,449.1) (2,385,375.6)
Promotional Expenses per year 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 Yearly Promotional Expenses
Investment Costs (3,500,000.0) (1,000,000.0)
&
D&A 350,000.0 350,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0
Reps = 2,000,000 €

1DETERMINISTIC MODEL
(EUR m) 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030

Sales forecast

Costs Assumptions
Raw Materials 6.39 6.39 6.39 6.39 6.39 6.39 6.39 6.39 6.39 6.39
Fixed Costs 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50
COGS x pack adjusted 9.07 9.25 9.44 9.63 9.82 10.01 10.21 10.42 10.63 10.84
Royalties (% of Gross Sales) 20% 20% 20% 20% 20% 20% 20% 20% 20% 20%
Royalties per year (1,460,000.0) (1,579,296.6) (1,704,467.1) (1,835,757.6) (1,973,423.4) (2,117,730.0) (2,181,685.5) (2,247,572.4) (2,315,449.1) (2,385,375.6)
Promotional Expenses per year 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0
Investment Costs (3,500,000.0) (1,000,000.0) Up-front payment of
D&A 350,000.0 350,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0
3,500,000 € (immediate),
1,000,000 € (third year);
amortization according to the
patent expiration date

1DETERMINISTIC MODEL
(EUR m) 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030

Sales forecast

Working Capital Assumptions


DSO 60 60 60 60 60 60 60 60 60 60
DSI 90 90 90 90 90 90 90 90 90 90
DPO 75 75 75 75 75 75 75 75 75 75
Working Capital per year 1,124,705 1,216,604 1,313,029 1,414,168 1,520,218 1,631,384 1,680,652 1,731,408 1,783,696 1,837,564
Δ Working Capital +91,900 +96,425 +101,139 +106,050 +111,166 +49,268 +50,756 +52,289 +53,868

Other Assumptions

Tax Rate 30%


WACC 8.5%

1DETERMINISTIC MODEL
(EUR m) 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030

Sales forecast

Working Capital Assumptions


DSO 60 60 60 60 60 60 60 60 60 60 DSO (days) = 60
DSI 90 90 90 90 90 90 90 90 90 90
DSI (days) = 90
DPO 75 75 75 75 75 75 75 75 75 75
DPO (days) = 75
Working Capital per year 1,124,705 1,216,604 1,313,029 1,414,168 1,520,218 1,631,384 1,680,652 1,731,408 1,783,696 1,837,564
Δ Working Capital +91,900 +96,425 +101,139 +106,050 +111,166 +49,268 +50,756 +52,289 +53,868

Other Assumptions

Tax Rate 30% Tax rate = 30%


WACC 8.5%
Weighted Average Cost
of Capital = 8.5%

1DETERMINISTIC MODEL
€5,192,027.7 29.19% 4.82YRS
NPV IRR PAYBACK PERIOD

1DETERMINISTIC MODEL
2STOCHASTIC MODEL
PATIENT STARTING EXPECTED RAW
GROWTH MARKET EXPECTED MATERIALS
GROWTH
RATE SHARE RATE INFLATION COST

Normal distribution Normal distribution Normal distribution Normal distribution Normal distribution
μ=1.06%/year μ=21.72% μ=0.57%/year μ=2.03%/year μ=6.39 EUR
σ=0.87%/year σ=1.25% σ=0.21%/year σ=0.81%/year σ=0.24 EUR

2STOCHASTIC MODEL
DISCOUNT DSO

Fitted to a Maximum Extreme distribution BetaPERT distribution


Likeliest = 4% Minimum = 56 days
Scale = 2% Likeliest = 67 days
Maximum = 72 days

PROMOTIONAL EXPENSES & REPS WACC

BetaPERT distribution BetaPERT distribution


Minimum = 1.7 million Minimum = 7.5%
Likeliest = 2 million Likeliest = 8.6%
Maximum = 2.2 million Maximum = 9.5%

2STOCHASTIC MODEL
NPV
450

400 Statistics: Forecast values


Base Case 5,192,027.7
350
Mean 6,640,269.7

300 Median 6,628,169.1


Standard Deviation 1,424,628.6
Frequency

250 Variance 2,029,566,626,290.3


Minimum 1,405,517.4
200 Maximum 12,771,309.4
Range Width 11,365,792.0
150
Mean Std. Error 10,073.6
100

50

0
2.726.798,8 4.691.918,4 6.657.037,9 8.622.157,5 10.587.277,1

2STOCHASTIC MODEL
IRR
450

400 Statistics: Forecast values


Base Case 29%
350
Mean 35%

300 Median 35%


Standard Deviation 6%
Frequency

250 Variance 0%
Minimum 14%
200 Maximum 61%
Range Width 47%
150
Mean Std. Error 0%
100

50

0
19% 27% 35% 43% 51%

2STOCHASTIC MODEL
PAYBACK PERIOD
0,8

0,7 Statistics: Forecast values


Base Case 4.00
0,6 Mean 3.85
Median 4.00
0,5 Standard Deviation 0.55
Variance 0.30
0,4 Minimum 3.00
Maximum 6.00
0,3 Range Width 3.00
Mean Std. Error 0.00
0,2

0,1

0
2 3 4 5 6

2STOCHASTIC MODEL
3STOCHASTIC MODEL W/
NEW COMPETITOR
New Assumptions :

We decided to create a positive correlation between Market Share Increase and the Weighted Average Commercial
Discount

Correlation Coefficient
= 0.53

3STOCHASTIC MODEL W/ NEW


COMPETITOR
New Assumptions :

We decided to create a custom distribution for every year in which the competitor could enter the market

P = 10 % P = 30 % P = 50 % P = 80 %
Market share decrease due to competitor Market share decrease due to competitor Market share decrease due to competitor Market share decrease due to competitor

3STOCHASTIC MODEL W/ NEW


COMPETITOR
NPV
400

350 Statistics: Forecast values


Base Case 5,192,027.7
300 Mean 3,108,234.2
Median 3,087,690.4
250 Standard Deviation 1,661,147.1
Frequency

Variance 2,759,409,593,561.4
200 Minimum (2,022,610.9)
Maximum 9,277,971.3
150 Range Width 11,300,612.2
Mean Std. Error 11,747.6
100

50

0
(1.504.537,8) 801.848,2 3.108.234,2 5.414.620,2 7.721.006,2

3STOCHASTIC MODEL W/ NEW


COMPETITOR
NPV
25000

20000

15000
Frequency

97.7% positive values


10000

5000

0
(1.504.537,8) 801.848,2 3.108.234,2 5.414.620,2 7.721.006,2

3STOCHASTIC MODEL W/ NEW


COMPETITOR
IRR
500

450
Statistics: Forecast values
400 Base Case 29%
Mean 26%
350 Median 27%
Standard Deviation 8%
300
Frequency

Variance 1%
250 Minimum -9%
Maximum 53%
200
Range Width 62%
150 Mean Std. Error 0%

100

50

0
4% 15% 26% 37% 48%

3STOCHASTIC MODEL W/ NEW


COMPETITOR
IRR
25000

20000

15000
Frequency

10000

5000

0
4% 15% 26% 37% 48%

3STOCHASTIC MODEL W/ NEW


COMPETITOR
PAYBACK PERIOD
0,8

0,7 Statistics: Forecast values


Base Case 4.00
0,6 Mean 3.92
Median 4.00
0,5 Standard Deviation 0.67
Variance 0.45
0,4 Minimum 3.00
Maximum 10.00
0,3 Range Width 7.00
Mean Std. Error 0.00
0,2

0,1

0
2 3 4 5 6 7 8 9 10 11

3STOCHASTIC MODEL W/ NEW


COMPETITOR

You might also like